Virtue Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-41,142	Closed	-$3.6M	–	97
2018 Q3	$3.6M	Buy	41,142 +25,865	+169%	+$2.26M	0.76%	42
2018 Q2	$1.51M	Buy	15,277 +7,413	+94%	+$730K	0.73%	36
2018 Q1	$754K	Buy	7,864 +4,531	+136%	+$434K	0.4%	78
2017 Q4	$423K	Buy	+3,333	New	+$423K	0.24%	117